Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News TRINITY BIOTECH PLC TRIB

Trinity Biotech PLC is an Ireland-based develops, acquires, manufactures and markets medical diagnostic systems, including both reagents and instrumentation for the clinical laboratory and point-of-care segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. Its... see more

Recent & Breaking News (NDAQ:TRIB)

Trinity Biotech Announces Q2 2023 Financial Results

GlobeNewswire October 3, 2023

Trinity Biotech plc to Announce Second Quarter Fiscal Year 2023 Financial Results

GlobeNewswire September 27, 2023

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Minimum Bid Price Requirement

GlobeNewswire September 11, 2023

Trinity Biotech Announces That It Has Received 510(k) Clearance From The U.S. Food and Drug Administration for the Premier Resolution System

GlobeNewswire August 7, 2023

Trinity Biotech Announces Q1 2023 Financial Results

GlobeNewswire July 6, 2023

Trinity Biotech plc to Announce First Quarter Fiscal Year 2023 Financial Results

GlobeNewswire July 3, 2023

Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

GlobeNewswire May 5, 2023

Trinity Biotech Announces the Successful Closing of the $30 Million Sale of its Life Sciences Supply Business to Biosynth

GlobeNewswire April 27, 2023

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Minimum Bid Price Requirement

GlobeNewswire April 24, 2023

Trinity Biotech Announces the $30 Million Sale of its Life Sciences Supply Business to Biosynth

GlobeNewswire April 20, 2023

Trinity Biotech Announces Fourth Quarter and Fiscal Year 2022 Financial Results

GlobeNewswire March 23, 2023

Trinity Biotech Welcomes TrinScreen HIV's Inclusion In The New Kenyan HIV Testing Algorithm

GlobeNewswire March 22, 2023

Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2022 Financial Results

GlobeNewswire March 16, 2023

Trinity Biotech Announces Entry Into An Increased Loan Facility to Fund Potential Acquisitions

GlobeNewswire February 22, 2023

Trinity Biotech Announces Strategic Partnership with imaware(TM) to Deliver Integrated Diagnostic Testing Solutions to Digital Health Industry

GlobeNewswire January 9, 2023

Trinity Biotech Announces Q3 2022 Financial Results

GlobeNewswire December 15, 2022

Trinity Biotech plc to Announce Third Quarter Fiscal Year 2022 Financial Results

GlobeNewswire December 9, 2022

Trinity Biotech to participate in the Piper Sandler 34th Annual Healthcare Conference

GlobeNewswire November 30, 2022

Trinity Biotech Announces Quarter 2 2022 Financial Results And Preliminary Q3 2022 Revenue Guidance

GlobeNewswire November 3, 2022

Trinity Biotech plc to Announce Second Quarter Fiscal Year 2022 Financial Results

GlobeNewswire November 1, 2022